Global Thematic Partners Cut Its 58 Com (WUBA) Position, Ophthotech (OPHT) Sentiment Is 0.69

June 8, 2017 - By Adrian Erickson

Global Thematic Partners Llc decreased 58 Com Inc (WUBA) stake by 5.59% reported in 2016Q4 SEC filing. Global Thematic Partners Llc sold 24,456 shares as 58 Com Inc (WUBA)’s stock rose 30.73%. The Global Thematic Partners Llc holds 412,923 shares with $11.56M value, down from 437,379 last quarter. 58 Com Inc now has $6.37 billion valuation. The stock increased 1.56% or $0.67 during the last trading session, reaching $43.67. About shares traded. 58.com Inc (ADR) (NYSE:WUBA) has declined 14.06% since June 8, 2016 and is downtrending. It has underperformed by 30.76% the S&P500.

Ophthotech Corporation is a biopharmaceutical company. The company has market cap of $88.91 million. The Firm is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. It currently has negative earnings. The Company’s primary focus is developing therapeutics for age-related macular degeneration , which is a disorder of the central portion of the retina, known as the macula, that may result in blindness.

Global Thematic Partners Llc increased Comcast Corp New (NASDAQ:CMCSA) stake by 53,614 shares to 1.07M valued at $74.18M in 2016Q4. It also upped Nike Inc (NYSE:NKE) stake by 110,835 shares and now owns 2.15 million shares. Cbre Group Inc (NYSE:CBG) was raised too.

Among 14 analysts covering 58.com (NYSE:WUBA), 6 have Buy rating, 2 Sell and 6 Hold. Therefore 43% are positive. 58.com had 19 analyst reports since August 21, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, November 11 by Credit Suisse. Deutsche Bank initiated 58.com Inc (ADR) (NYSE:WUBA) rating on Wednesday, October 5. Deutsche Bank has “Buy” rating and $65 target. The firm has “Overweight” rating given on Tuesday, September 1 by Morgan Stanley. The stock of 58.com Inc (ADR) (NYSE:WUBA) has “Underperform” rating given on Friday, November 11 by CLSA. Deutsche Bank downgraded the shares of WUBA in report on Wednesday, December 14 to “Hold” rating. The firm has “Neutral” rating given on Friday, November 11 by Brean Capital. Credit Agricole initiated it with “Sell” rating and $48 target in Thursday, October 15 report. The firm has “Outperform” rating by CLSA given on Friday, May 26. Bernstein initiated it with “Underperform” rating and $25 target in Wednesday, January 11 report. On Tuesday, November 15 the stock rating was downgraded by HSBC to “Hold”.

Prescott Group Capital Management L.L.C. holds 0.49% of its portfolio in Ophthotech Corp for 480,036 shares. Bogle Investment Management L P De owns 1.28 million shares or 0.43% of their US portfolio. Moreover, Quinn Opportunity Partners Llc has 0.37% invested in the company for 253,870 shares. The New York-based Geduld E E has invested 0.14% in the stock. Tourbillon Capital Partners L.P., a New York-based fund reported 1.36 million shares.

Since January 1, 0001, it had 0 insider purchases, and 12 insider sales for $17.74 million activity.

Analysts await Ophthotech Corp (NASDAQ:OPHT) to report earnings on August, 2. They expect $-1.06 earnings per share, down 24.71% or $0.21 from last year’s $-0.85 per share. After $-1.20 actual earnings per share reported by Ophthotech Corp for the previous quarter, Wall Street now forecasts -11.67% EPS growth.

The stock increased 0.81% or $0.02 during the last trading session, reaching $2.49. About shares traded. Ophthotech Corp (OPHT) has declined 94.82% since June 8, 2016 and is downtrending. It has underperformed by 111.52% the S&P500.

Ratings analysis reveals 0 of Ophthotech’s analysts are positive. Out of 6 Wall Street analysts rating Ophthotech, 0 give it “Buy”, 0 “Sell” rating, while 6 recommend “Hold”. OPHT was included in 6 notes of analysts from December 12, 2016. The firm has “Neutral” rating given on Tuesday, December 13 by Goldman Sachs. Leerink Swann downgraded Ophthotech Corp (NASDAQ:OPHT) on Monday, December 12 to “Mkt Perform” rating. The firm has “Neutral” rating by Chardan Capital Markets given on Monday, December 12. The stock of Ophthotech Corp (NASDAQ:OPHT) earned “Hold” rating by Gabelli on Tuesday, December 13. The stock of Ophthotech Corp (NASDAQ:OPHT) earned “Neutral” rating by Citigroup on Monday, December 12. JP Morgan downgraded Ophthotech Corp (NASDAQ:OPHT) on Monday, December 12 to “Neutral” rating.